Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rheumatoid Arthritis(RA)”

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07207954
What this trial is testing

Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Lifordi Immunotherapeutics, Inc. 176
Not applicableUnknownNCT04569890
What this trial is testing

Treatment of Pregnancy RA

Who this might be right for
Rheumatoid ArthritisPregnancy Related
RenJi Hospital 100
Large-scale testing (Phase 3)Study completedNCT02305849
What this trial is testing

Evaluate Efficacy and Safety of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate (MTX) Treatment

Who this might be right for
Rheumatoid Arthritis
Astellas Pharma Inc 519
Post-approval studies (Phase 4)Study completedNCT00650455
What this trial is testing

Efficacy and Safety of Valdecoxib and Naproxen in Treating the Signs and Symptoms of Rheumatoid Arthritis (RA) in a Severe Rheumatoid Arthritis Patients

Who this might be right for
Arthritis, Rheumatoid
Pfizer 489
Not applicableStudy completedNCT02350491
What this trial is testing

Study During Pregnancy of Expression of miRNAs in RA or SLE

Who this might be right for
Rheumatoid ArthritisSystemic Lupus Erythematosus
University Hospital, Strasbourg, France 50
Large-scale testing (Phase 3)Ended earlyNCT02930343
What this trial is testing

Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy

Who this might be right for
Rheumatoid Arthritis
Jawaharlal Institute of Postgraduate Medical Education & Research 136
Large-scale testing (Phase 3)Study completedNCT00239382
What this trial is testing

Compare Meloxicam IM Once Daily Versus Meloxicam Orally Once Daily in Patients With Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Boehringer Ingelheim 150
Testing effectiveness (Phase 2)Study completedNCT01960855
What this trial is testing

A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy

Who this might be right for
Rheumatoid Arthritis
AbbVie 276
Testing effectiveness (Phase 2)Study completedNCT01313520
What this trial is testing

Evaluate the Effectiveness of Infliximab and Changes in Hand and Wrist Magnetic Resonance Imaging (MRI) in Participants With Active Rheumatoid Arthritis (RA) (P08136)

Who this might be right for
Arthritis, Rheumatoid
Merck Sharp & Dohme LLC 61
Post-approval studies (Phase 4)UnknownNCT01835613
What this trial is testing

Evaluation Effects of Treatment With IL-6R Inhibitor on Clinical Response and Biomarkers in Patients With Rheumatoid Arthritis (RA) Not Responding to DMARDs and/or a First Biological Agent.

Who this might be right for
Rheumatoid Arthritis (RA)
Osservatorio Epidemiologico GISEA 150
Testing effectiveness (Phase 2)Study completedNCT05516979
What this trial is testing

A Safety & Efficacy Study of Treatment With AP1189 in Rheumatoid Arthritis Patients naïve to DMARD Treatment

Who this might be right for
Rheumatoid Arthritis
SynAct Pharma Aps 127
Not applicableStudy completedNCT04428424
What this trial is testing

Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients

Who this might be right for
Arthritis, Rheumatoid
Pfizer 1,493
Early research (Phase 1)Study completedNCT06213259
What this trial is testing

KD6005 in Healthy Participants and Participants With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Shanghai Kanda Biotechnology Co., Ltd. 73
Not applicableStudy completedNCT02620189
What this trial is testing

Th17 Responses Evaluated in RA Patients on Inhibitors of TNFα

Who this might be right for
Rheumatoid Arthritis
Queen Mary University of London 60
Large-scale testing (Phase 3)Study completedNCT00996606
What this trial is testing

Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 58
Early research (Phase 1)Study completedNCT01253226
What this trial is testing

Japanese Participants With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 32
Post-approval studies (Phase 4)Study completedNCT01500278
What this trial is testing

Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate

Who this might be right for
Rheumatoid Arthritis
UCB Pharma SA 915
Testing effectiveness (Phase 2)Study completedNCT00000435
What this trial is testing

DnaJ Peptide for Relieving Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 160
Large-scale testing (Phase 3)Study completedNCT02720523
What this trial is testing

Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDs

Who this might be right for
Rheumatoid Arthritis
AbbVie 197
Large-scale testing (Phase 3)Study completedNCT00117091
What this trial is testing

Anakinra (Kineret®) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Amgen
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation